CUBERES-ALTISENT,, María Rosa,SOLÀ - CARANDELL, Lluis,GARCÍA - COUCEIRO,, Urko
申请号：
MEP17316
公开号：
ME02481B
申请日:
2010.11.25
申请国别(地区):
ME
年份:
2017
代理人:
摘要：
The present invention relates to 4-[-2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.
